Indefinite Delivery Contract 75N93019D00002

Award Date 1/11/19
Last Date to Order 1/14/26
Ultimate Awardee
Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million to be delivered through January 2026 in support of the National Institutes of Health's infectious disease research programs. Under the first delivery order valued at $2,500, Atcc...
The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million and period of performance through January 2026. ATCC received a $2,500 delivery order against this master contract for assessments to take place at...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to American Type Culture Collection to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. With a potential value of $30 million and a period of performance from January 2023 through September 2030, the contract enables task orders to be issued across five areas: product...
The Department of Health and Human Services, through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a single-award Indefinite Delivery Contract valued at $146.3 million to the American Type Culture Collection (ATCC), a nonprofit organization, to provide a range of preclinical infectious disease models and specialized reagents. The contract aims to support the development, refinement, and utilization of animal and animal replacement models to evaluate candidate medical...
This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to American Type Culture Collection (ATCC), a nonprofit biological resource center. The contract has a ceiling value of $136,588,701.00 and a period of performance through September 29, 2035. The purpose of this IDC is to provide evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases. ATCC, as the prime...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to the American Type Culture Collection to provide a quality-assured central repository for the acquisition, authentication, storage, inventory, and distribution of a broad range of biological materials. The contract has a potential value of $545,452,906 over a seven year ordering period ending August 2028. Under the contract, two delivery orders have been...
The National Institute of Allergy and Infectious Diseases has awarded an indefinite delivery contract with a potential value of $107,274,471 to multiple prime contractors to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. Task orders will be issued under seven task areas, including in vitro testing, synthesis of therapeutic agents, small animal...
The American Type Culture Collection (ATCC), a nonprofit biological resource center, has been awarded an Indefinite Delivery Contract (IDC) by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency. The contract has a ceiling value of $250,000,000 and a period of performance through August 21, 2025. Under this IDC, ATCC will provide a broad range of specialized biological services and support to ASPR, including storage and distribution of biological...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract vehicle known as the In Vitro Assessments of Antimicrobial Activity master contract to the University of Alabama at Birmingham as prime contractor. The master contract has a potential value of $30 million and period of performance from January 2019 through January 2026. Under the master contract, the National Institute of Allergy and Infectious Diseases has issued...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the American Type Culture Collection (ATCC), a nonprofit biological resource center located in Manassas, Virginia. The contract has a $148,000,000 ceiling value and a period of performance through September 29, 2030. The contract, which was not set aside for any particular business type, is a multiple award IDC for "DIAGNOSTIC TESTING IDIQ" services. Under this IDC, ATCC...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a multiple award indefinite delivery contract to the American Type Culture Collection for in vitro assessments of antimicrobial activity and related biological products and services. The master contract has a potential value of $30 million over its period of performance from January 2019 to January 2026.

Two task orders have been issued against the contract to date. A $3.08 million order was awarded in January 2022 for the production of well-characterized biosafety level three and four viral challenge materials at ATCC's Manassas, Virginia facility over 25 months. An earlier $2,500 firm fixed price order issued in January 2019 involves in vitro antimicrobial assessments to be completed by September 2020 at the same location. Neither task order utilized set-asides.

The original solicitation sought support for the NIH's infectious disease research through the contracted provision of reference microorganisms and other biological materials, as well as laboratory testing services. ATCC will leverage its capabilities in pathogen storage, processing of biospecimens, and manufacturing of products for vaccine, therapeutic and diagnostic development under the contract. Task orders to date further the goals of generating characterized viral reagents and conducting antimicrobial susceptibility screening.

Generated 1/25/24, 9:10 AM